VSEE HEALTH, INC. (VSEEW)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-03-24

Key Insights

The reporting person, Imoigele Aisiku, who is the Co-Chief Executive Officer of VSEE HEALTH, INC. (VSEEW), has acquired a significant amount of the company's common stock through a series of quarterly equity awards pursuant to his employment agreement.
The shares were acquired at prices ranging from $0.37 to $1.20 per share, indicating the company's stock price has increased over the past year.
The insider buying activity suggests the reporting person has confidence in the company's future performance and aligns his interests with those of other shareholders.

Insider Trading Filed: 2026-03-24

Key Insights

Insider Jerry Leonard acquired a total of 150,214 shares of VSEE Health, Inc. (VSEEW) over the past year through quarterly equity awards, indicating his commitment to the company's long-term success.
The shares were acquired at various prices ranging from $0.37 to $1.20 per share, suggesting that the company's stock may be undervalued and presenting a potential opportunity for investors.
The consistent pattern of insider buying over the past year could be a positive signal for the company's financial performance and growth prospects.

Insider Trading Filed: 2026-01-16

Key Insights

The reporting person, Cydonii V. Fairfax, acquired a significant number of shares of VSEE Health, Inc. common stock over the past year, indicating their confidence in the company's growth potential.
The shares were acquired through the company's 2024 Incentive Plan as part of the non-employee director compensation policy, suggesting the company is aligning the interests of its directors with shareholders.
The timing and pricing of the share acquisitions suggest the reporting person believes the stock is undervalued, which could signal an attractive investment opportunity for investors.

Insider Trading Filed: 2026-01-16

Key Insights

The reporting person, Colin P. O'Sullivan, acquired a significant number of shares in VSEE Health, Inc. (VSEE) between September 2024 and September 2025, suggesting potential insider confidence in the company's future.
The shares were acquired under the company's 2024 Incentive Plan as part of the non-employee director compensation policy, indicating the reporting person's active involvement in the company's governance.
The acquisition prices range from $0.69 to $2.31 per share, providing insight into the company's stock valuation during this period.

Insider Trading Filed: 2026-01-16

Key Insights

The reporting person, Kevin Lowdermilk, is a director of VSEE Health, Inc. and has been acquiring shares of the company's common stock over the past several quarters as part of their non-employee director compensation.
The total number of shares beneficially owned by Lowdermilk has increased from 227 shares as of June 30, 2024 to 10,294 shares as of September 19, 2025, indicating their ongoing commitment to the company.
The shares were acquired at prices ranging from $0.69 to $2.31 per share, which suggests the company's stock may be reasonably valued and attractive to insiders.

Insider Trading Filed: 2026-01-16

Key Insights

The filing indicates that the reporting person, Scott Metzger, has been consistently acquiring VSEE Health, Inc. (VSEE) common stock over the past 2 years as part of the company's non-employee director compensation plan.
The reported transactions show that Metzger has acquired a total of 77,249 shares of VSEE stock through multiple tranches, suggesting his commitment to the company and alignment with shareholder interests.
The consistent nature of these insider purchases, along with the gradual increase in share price from $0.69 to $2.31, may indicate positive market sentiment and growth potential for VSEE.

Insider Trading Filed: 2026-01-16

Key Insights

The reporting person, David L. Wickersham, acquired a significant amount of common stock in VSEE Health, Inc. through several transactions in 2024 and 2025, suggesting his confidence in the company's prospects.
The shares were acquired at various prices, ranging from $0.69 to $1.49 per share, indicating a consistent investment strategy over time.
The large number of shares acquired, totaling over 260,000, suggests Wickersham's substantial ownership stake and alignment with other shareholders.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.